Jordi Xaus
Chief Tech/Sci/R&D Officer chez ORYZON GENOMICS S.A.
Profil
Jordi Xaus is currently the Chief Scientific Officer at Oryzon Genomics SA since 2021.
Previously, he worked as the Director & Biomedicine Director at Biosearch SA. He also served as an Associate Professor at the University of Barcelona from 2000 to 2001.
Additionally, he held the position of Chief Scientific Officer at Palau Pharma SA. Dr. Xaus obtained a doctorate degree from the University of Barcelona in 1994, followed by a graduate degree in 1997.
He later earned another graduate degree from Ramon Llull University in 2009.
Postes actifs de Jordi Xaus
Sociétés | Poste | Début |
---|---|---|
ORYZON GENOMICS S.A. | Chief Tech/Sci/R&D Officer | 01/07/2021 |
Anciens postes connus de Jordi Xaus
Sociétés | Poste | Fin |
---|---|---|
University of Barcelona | Corporate Officer/Principal | 01/01/2001 |
BIOSEARCH, S.A. | Director/Board Member | - |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Chief Tech/Sci/R&D Officer | - |
Formation de Jordi Xaus
University of Barcelona | Doctorate Degree |
Ramon Llull University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Entreprise privées | 2 |
---|---|
Biosearch SA
Biosearch SA Pharmaceuticals: OtherHealth Technology Biosearch SA engages in the provision of products for pharmaceutical, nutritional, and functional food sectors. It develops and markets three product platforms including Omega-3, Probiotics and Botanical Extracts. The company was founded on September 12, 2000 and is headquartered in Granada, Spain. | Health Technology |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Health Technology |